Labcorp (LH) director Richelle Parham awarded 773 new restricted stock units

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Richelle P. Parham received a new equity award in the form of restricted stock units. On February 10, 2026, she acquired 773 Restricted Stock Units, each representing the right to receive one share of Labcorp common stock, at no cash cost.

The Restricted Stock Units vest fully on February 10, 2027, meaning the shares will be delivered if the vesting conditions are satisfied. After this grant, Parham beneficially holds a total of 1,670 Restricted Stock Units directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parham Richelle P

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/10/2026		A		773		(2)	(2)	Common Stock	773	$0	1,670(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on February 10, 2027.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Richelle P. Parham	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Labcorp (LH) report for Richelle P. Parham?

Labcorp reported that director Richelle P. Parham received a grant of 773 Restricted Stock Units on February 10, 2026. These units are a form of stock-based compensation and increase her directly held restricted stock units to a total of 1,670 after the grant.

How many Restricted Stock Units did Richelle P. Parham receive from Labcorp (LH)?

Richelle P. Parham was granted 773 Restricted Stock Units. Each unit gives her the contingent right to receive one share of Labcorp common stock, subject to vesting. This award is in addition to units she already held before the reported transaction.

When do Richelle P. Parham’s Labcorp (LH) Restricted Stock Units vest?

Parham’s Restricted Stock Units vest fully on February 10, 2027. Vesting means she will receive the underlying Labcorp common shares on that date, assuming all vesting conditions are satisfied and she continues to meet the award’s terms.

What is the total number of Labcorp (LH) Restricted Stock Units Parham holds after this grant?

Following the February 10, 2026 grant, Parham beneficially owns 1,670 Restricted Stock Units. This figure reflects the aggregate number of RSUs held directly by her, including the newly awarded 773 units reported in the Form 4 filing.

Does Richelle P. Parham’s RSU grant from Labcorp (LH) involve an immediate cash payment?

No, the Restricted Stock Unit grant does not involve an immediate cash payment. The units were acquired at a stated price of $0.00 per unit, representing stock-based compensation rather than a traditional share purchase in the open market.

What does each Labcorp (LH) Restricted Stock Unit granted to Parham represent?

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock. Delivery of those shares occurs only if the units vest under the award’s terms, including the full vesting date of February 10, 2027.